Avitide Overview
- Year Founded
-
2012

- Status
-
Acquired/Merged
- Employees
-
29

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$275M
Avitide General Information
Description
Developer a molecule-specific affinity purification technology designed to improve drug safety and establish bio similarity. The company's technology focuses on purifying therapeutic proteins, and uses rapid development of chromatography resins via chemical synthesis, enabling partners to achieve speeded bioprocess development timelines, reduced program risk, predictable commercial scalability, and lower cost of manufacturing for batch and continuous operations.
Contact Information
Website
www.avitide.com(Operating Subsidiary)
Corporate Office
- 16 Cavendish Court
- Lebanon, NH 03766
- United States
Corporate Office
- 16 Cavendish Court
- Lebanon, NH 03766
- United States
Avitide Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 30-Sep-2021 | $275M | Completed | Generating Revenue | ||
8. Later Stage VC (Series H) | 23-Oct-2019 | Completed | Generating Revenue | |||
7. Later Stage VC (Series G) | 23-Aug-2018 | Completed | Generating Revenue | |||
6. Later Stage VC (Series F) | 02-Jan-2018 | Completed | Generating Revenue | |||
5. Later Stage VC (Series E) | 26-Jun-2017 | Completed | Generating Revenue | |||
4. Later Stage VC (Series D) | 12-Sep-2016 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | 06-Aug-2015 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B) | 09-Jun-2014 | $3.44M | $4.89M | Completed | Startup | |
1. Early Stage VC (Series A) | 04-Mar-2013 | $1.45M | $1.45M | Completed | Startup |
Avitide Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series H | ||||||||
Series G | ||||||||
Series F | ||||||||
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 918,450 | $0.000100 | $3.74 | $3.74 | 1x | $3.74 | 10.92% | |
Series A | 783,422 | $0.000100 | $1.87 | $1.87 | 1x | $1.87 | 9.32% |
Avitide Comparisons
Industry
Financing
Details
Avitide Competitors (25)
One of Avitide’s 25 competitors is ToolGen, a Corporation company based in Seoul, South Korea.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ToolGen | Corporation | Seoul, South Korea | ||||
Menarini Silicon Biosystems | Formerly VC-backed | Castel Maggiore, Italy | ||||
Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
Quantapore | Venture Capital-Backed | South San Francisco, CA | ||||
Sphere Fluidics | Venture Capital-Backed | Cambridge, United Kingdom |
Avitide Signals
Avitide Former Investors (12)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Angeli Parvi | Angel Group | Minority | ||
Borealis Ventures | Venture Capital | Minority | ||
Angel (individual) | Minority | |||
Angel (individual) | Minority | |||
Mithril Capital Management | Venture Capital | Minority |
Avitide FAQs
-
When was Avitide founded?
Avitide was founded in 2012.
-
Where is Avitide headquartered?
Avitide is headquartered in Lebanon, NH.
-
What is the size of Avitide?
Avitide has 29 total employees.
-
What industry is Avitide in?
Avitide’s primary industry is Biotechnology.
-
Is Avitide a private or public company?
Avitide is a Private company.
-
What is the current valuation of Avitide?
The current valuation of Avitide is
. -
What is Avitide’s current revenue?
The current revenue for Avitide is
. -
How much funding has Avitide raised over time?
Avitide has raised $48.7M.
-
Who are Avitide’s investors?
Angeli Parvi, Borealis Ventures, , , and Mithril Capital Management are 5 of 12 investors who have invested in Avitide.
-
Who are Avitide’s competitors?
ToolGen, Menarini Silicon Biosystems, Egenesis, Quantapore, and Sphere Fluidics are some of the 25 competitors of Avitide.
-
When was Avitide acquired?
Avitide was acquired on 30-Sep-2021.
-
Who acquired Avitide?
Avitide was acquired by Repligen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »